Journey of Resilience
Overcoming Endometrioid Carcinoma: A Patient’s Journey to Recovery
Diagnosis to Hope: A 45-Year-Old Patient’s Triumph Over Cancer
A 45-year-old woman with a history of type 2 diabetes was diagnosed with endometrioid carcinoma, a type of ovarian cancer, after experiencing chronic abdominal and pelvic pain. Routine tests revealed elevated CA-125 levels (94 U), and imaging studies identified a solid ovarian tumor and a uterine anomaly (uterus didelphys).
Following a comprehensive surgical procedure, including the removal of the affected ovary, complete surgical staging, and a hysterectomy, the patient’s condition was formally classified as stage IC2, moderately differentiated endometrioid carcinoma. The pathology report confirmed no metastatic spread, a promising sign for her prognosis.
To reduce the risk of recurrence, the patient underwent six cycles of chemotherapy with carboplatin and paclitaxel, which she tolerated well. Now, 11 months after her diagnosis, she remains cancer-free, under regular medical surveillance, and without additional clinical concerns.
Her journey highlights the importance of early detection, comprehensive treatment, and continuous follow-up in achieving the best possible outcome.
Diagnosis
Endometrioid carcinoma (Stage IC2) discovered through chronic pelvic pain and high CA-125 levels
Biomarker profile: Not reported
Treatment
Surgical tumor removal, hysterectomy, and six cycles of chemotherapy
Outcome
Currently disease-free, with no signs of recurrence after nearly a year
Source: Ginecol Obstet Mex